Design, synthesis and structure–activity relationship studies of novel and diverse cyclooxygenase-2 inhibitors as anti-inflammatory drugs

Funk CD, 1991, FASEB J, 5, 2304, 10.1096/fasebj.5.9.1907252

Patrignani P, 1994, J Pharmacol Exp Ther, 271, 1705

Smith WL, 1996, J Biol Chem, 271, 33157, 10.1074/jbc.271.52.33157

Simmons DL, 2004, Pharmacol Rev, 56, 387, 10.1124/pr.56.3.3

10.1016/j.bcp.2006.07.037

Kojima F, 2006, Expert Rev Clin Immunol, 2, 277, 10.1586/1744666X.2.2.277

Kang RY, 1996, Br J Rheumatol, 35, 711, 10.1093/rheumatology/35.8.711

Blatteis CM, 2006, Pharmacol Ther, 111, 194, 10.1016/j.pharmthera.2005.10.013

Ivanov AI, 2002, Am J Physiol Regul Integr Comp Physiol, 283, R1104, 10.1152/ajpregu.00347.2002

Romanovsky AA, 2005, Front Biosci, 10, 2193, 10.2741/1690

Steiner AA, 2006, PLoS Biol, 4, 1517, 10.1371/journal.pbio.0040284

Li S, 1999, Brain Res, 825, 86, 10.1016/S0006-8993(99)01225-1

10.1016/S0049-3848(03)00379-7

Burian M, 2005, Pharmacol Ther, 107, 139, 10.1016/j.pharmthera.2005.02.004

10.1097/00005344-200605001-00011

10.1016/j.etp.2006.06.004

Warner TD, 1999, Proc Natl Acad Sci USA, 96, 7563, 10.1073/pnas.96.13.7563

Hla T, 1992, Proc Natl Acad Sci USA., 89, 7384, 10.1073/pnas.89.16.7384

10.1016/0014-5793(93)80263-T

Beiche F, 1996, FEBS Lett, 390, 165, 10.1016/0014-5793(96)00604-7

Steer SA, 2003, Viral Immunol, 16, 447, 10.1089/088282403771926283

Duque J, 2006, Cell Signal, 18, 1262, 10.1016/j.cellsig.2005.10.009

10.1093/carcin/18.4.795

Kiritoshi S, 2003, Potential role in diabetic nephropathy. Diabetes, 52, 2570

Hayashi S, 2011, Biochem Pharmacol, 82, 755, 10.1016/j.bcp.2011.06.036

Kowalski ML, 2006, Safety of cyclo-oxygenase-2 inhibitors. Treat Respir Med, 5, 399, 10.2165/00151829-200605060-00005

Sánchez-Borges M, 2010, Med Clin North Am, 94, 853, 10.1016/j.mcna.2010.03.005

Harrington LS, 2008, FASEB J, 22, 4005, 10.1096/fj.08-107979

Reddy BS, 2002, J Environ Pathol Toxicol Oncol, 21, 155, 10.1615/JEnvironPatholToxicolOncol.v21.i2.90

Tsuji M, 1997, Proc Natl Acad Sci USA, 94, 3336, 10.1073/pnas.94.7.3336

Wu K, 2009, J Gastroenterol Hepatol, 24, 37, 10.1111/j.1440-1746.2008.05753.x

Jüttner S, 2003, Cell Microbiol, 5, 821, 10.1046/j.1462-5822.2003.00324.x

Ku GY, 2010, Cancer Treat Rev, 36, 235, 10.1016/j.ctrv.2009.12.009

Saadi A, 2010, Proc Natl Acad Sci USA, 107, 2177, 10.1073/pnas.0909797107

10.1016/S0041-008X(03)00301-6

Camp WL, 2011, Semin Cutan Med Surg, 30, 6, 10.1016/j.sder.2011.01.003

Mao Y, 2013, Cancer Res, 73, 3877, 10.1158/0008-5472.CAN-12-4115

Krysan K, 2006, Anti-Cancer Agents Med Chem, 6, 209, 10.2174/187152006776930882

Yuan A, 2005, Int J Cancer, 115, 545, 10.1002/ijc.20898

Sato M, 2012, Respirology, 17, 1048, 10.1111/j.1440-1843.2012.02173.x

Kew MC, 2011, J Gastroenterol Hepatol, 26, 144, 10.1111/j.1440-1746.2010.06546.x

Fernández-Martínez A, 2006, Biochem J, 398, 371, 10.1042/BJ20060780

10.1002/hep.23052

Zhao Q-T, 2007, Life Sci, 80, 484, 10.1016/j.lfs.2006.09.038

Mohammed A, 2012, Int J Cancer, 131, 1951, 10.1002/ijc.27456

10.1002/1097-0142(20010115)91:2<333::AID-CNCR1006>3.0.CO;2-N

Niijima M, 2002, Cancer, 94, 1565, 10.1002/cncr.10358

Hayashi N, 2001, Hepatology, 34, 638, 10.1053/jhep.2001.28198

Kawamoto T, 2002, Int J Cancer, 98, 427, 10.1002/ijc.10222

10.1002/1097-0142(20010701)92:1<188::AID-CNCR1308>3.0.CO;2-W

Hu M, 2009, Proc Natl Acad Sci USA, 106, 3372, 10.1073/pnas.0813306106

Barnes NLP, 2007, Br J Cancer, 96, 575, 10.1038/sj.bjc.6603593

Jain S, 2006, Cancer Res, 66, 6638, 10.1158/0008-5472.CAN-06-0661

Badawi AF, 2000, BJU Int, 85, 451, 10.1046/j.1464-410x.2000.00507.x

Lee S, 2010, Immunology, 132, 410, 10.1111/j.1365-2567.2010.03377.x

Kim YB, 2002, Cancer, 95, 531, 10.1002/cncr.10684

10.1002/ijc.24757

Xin B, 2007, Cancer, 110, 791, 10.1002/cncr.22854

Murono S, 2001, Proc Natl Acad Sci USA, 98, 6905, 10.1073/pnas.121016998

10.1016/j.jdsr.2007.10.003

Iwata C, 2007, Cancer Res, 67, 10181, 10.1158/0008-5472.CAN-07-2366

Liu H, 2009, Anat Rec, 292, 1577, 10.1002/ar.20940

10.1054/bjoc.2000.1270

Tomozawa S, 1999, Br J Cancer, 81, 1274, 10.1038/sj.bjc.6694262

Chen J-H, 2006, Cancer Lett, 239, 263, 10.1016/j.canlet.2005.08.026

Kobayashi H, 2004, Int J Cancer, 112, 920, 10.1002/ijc.20523

Yao M, 2004, Br J Cancer, 90, 712, 10.1038/sj.bjc.6601489

Nagatsuka I, 2002, Int J Cancer, 100, 515, 10.1002/ijc.10508

10.1002/1097-0215(200102)9999:9999<894::AID-IJC1146>3.0.CO;2-#

Mougiakakos D, 2010, Cancer, 116, 2224, 10.1002/cncr.24999

Kim H-S, 2012, Biochem Pharm, 83, 385, 10.1016/j.bcp.2011.11.008

Said N, 2012, Life Sci, 91, 522, 10.1016/j.lfs.2012.03.040

Valsecchi ME, 2009, Clin Breast Cancer, 9, 225, 10.3816/CBC.2009.n.038

Ono K, 2002, J Bone Miner Res, 17, 774, 10.1359/jbmr.2002.17.5.774

Wu KK, 2007, Prostaglandins Other Lipid Mediat, 83, 175, 10.1016/j.prostaglandins.2007.01.002

10.1002/cncr.11437

Ali-Fehmi R, 2003, Cancer, 98, 1423, 10.1002/cncr.11650

Dormond O, 2001, Nat Med, 7, 1041, 10.1038/nm0901-1041

Connolly EM, 2002, Br J Cancer, 87, 231, 10.1038/sj.bjc.6600462

10.1002/ijc.1376

Chang S-H, 2004, Proc Natl Acad Sci USA, 101, 591, 10.1073/pnas.2535911100

10.1038/sj.bjc.6604057

Oshima H, 2010, Pathol Int, 60, 599, 10.1111/j.1440-1827.2010.02567.x

Qualtrough D, 2007, Int J Cancer, 121, 734, 10.1002/ijc.22755

Sales KJ, 2009, Biochim Biophys Acta, 1793, 1917, 10.1016/j.bbamcr.2009.09.018

Sakai H, 2006, FEBS Lett, 580, 3368, 10.1016/j.febslet.2006.05.007

Nie D, 2000, Biochem Biophys Res Commun, 267, 245, 10.1006/bbrc.1999.1840

Cline SD, 2004, Proc Natl Acad Sci USA, 101, 7275, 10.1073/pnas.0402252101

Mao H, 1999, Proc Natl Acad Sci USA, 96, 6615, 10.1073/pnas.96.12.6615

Flockhart RJ, 2008, FASEB J, 22, 4218, 10.1096/fj.08-113076

Fritsche E, 2007, Proc Natl Acad Sci USA, 104, 8851, 10.1073/pnas.0701764104

Zhou H, 2005, Proc Natl Acad Sci USA, 102, 14641, 10.1073/pnas.0505473102

Hussain M, 2012, Pharmacol Res, 66, 7, 10.1016/j.phrs.2012.02.003

White WB, 2003, Am J Cardiol, 92, 411, 10.1016/S0002-9149(03)00659-3

Hinz B, 2007, Nat Clin Pract Rhum, 3, 552, 10.1038/ncprheum0619

Oitate M, 2007, Drug Metab Dispos, 35, 1846, 10.1124/dmd.107.016121

Chenevard R, 2003, Circulation J Am Heart Assoc, 107, 405

Höcherl K, 2002, Hypertension J Am Heart Assoc, 40, 947

Limongelli V, 2010, Proc Natl Acad Sci USA, 107, 5411, 10.1073/pnas.0913377107

10.1073/pnas.0909765106

Kurumbail RG, 1996, Nature, 384, 644, 10.1038/384644a0

10.1074/jbc.271.26.15810

Luong C, 1996, Nat Struct Biol, 3, 927, 10.1038/nsb1196-927

Hayashi S, 2012, Eur J Med Chem, 50, 179, 10.1016/j.ejmech.2012.01.053

Katritzky AR, 1985, Tetrahedron Lett, 26, 5935, 10.1016/S0040-4039(00)98265-0

Baciocchi E, 1993, J Org Chem, 58, 7610, 10.1021/jo00078a055

Artis DR, 1992, Can J Chem, 70, 1838, 10.1139/v92-228

Nahm S, 1981, Tetrahedron Lett, 22, 3815, 10.1016/S0040-4039(01)91316-4

Moyer MP, 1986, J Org Chem, 51, 5106, 10.1021/jo00376a010

Frye SV, 1991, J Org Chem, 56, 3750, 10.1021/jo00011a066

Giordano C, 1992, J Org Chem, 57, 2765, 10.1021/jo00036a001

Bellucci G, 1986, 2. Kinetic and product investigation of the bromination of 3-substituted cylohexenes. J Org Chem, 51, 4224

10.1038/sj.bjp.0701076

Moore PF, 1996, Inflammation Res, 45, 54, 10.1007/BF02265116

Winter CA, 1962, Proc Soc Exp Biol Med, 111, 544, 10.3181/00379727-111-27849

Lombardino JG, 1975, Arzneim Forsch, 25, 1629

Gracia Leme J, 1973, Br J Pharmacol, 48, 88, 10.1111/j.1476-5381.1973.tb08225.x

Opas EE, 1987, Biochem Pharmacol, 36, 547, 10.1016/0006-2952(87)90365-0

Patel BA, 1977, J Org Chem, 42, 3903, 10.1021/jo00444a023

Carling RW, 1993, J Med Chem, 36, 3397, 10.1021/jm00074a021

10.1073/pnas.88.7.2692

10.1016/S0163-7827(00)00008-4

Romano M, 1997, Role of tumour necrosis factor. Mediat Inflamm, 6, 32, 10.1080/09629359791901

Padi SSV, 2004, Eur J Pharmacol, 491, 69, 10.1016/j.ejphar.2004.03.013

10.1038/sj.bjp.0705650

Claudino RF, 2006, J Pharmacol Exp Ther, 318, 611, 10.1124/jpet.106.102806